Application no. and date | 06794604.6 (espacenet) (Federated) (European Patent Register), 20060929 | Patent/reg. no. and date | DK/EP 1942939, 20180530 | Publication date | 20080716 | Priority no. and date | US 721974 P, 20050930, GB 0519923, 20050930 | EP pub. no. and date |
EP 1942939 20080716 | Effective date | | Applicant/owner | MEDIMMUNE LIMITED, Milstein Building Granta Park
Cambridge Cambridgeshire CB21 6GH, GB | Applicant ref. no. | P238820DKEP | Inventor | FISH, Brendan, Cormick, Cambridge Antibody Technology Limited Milstein Building Granta Park
Cambridge CB1 6GH, GB, LANGSTONE, Jeanette, Elizabeth, Cambridge Antibody Technology Limited Milstein Building Granta Park
Cambridge CB1 6GH, GB, BANNISTER, Karen, Cambridge Antibody Technology Limited Milstein Building Granta Park
Cambridge CB1 6GH, GB, HOPE, Claire, Louise, Cambridge Antibody Technology Limited Milstein Building Granta Park
Cambridge CB1 6GH, GB | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 47/02 (2006.01) , A61K 47/12 (2006.01) , A61K 47/26 (2006.01) , A61K 9/00 (2006.01) , C07K 16/24 (2006.01) | Title | Interleukin-13-antistofsammensætning | Int. application no. | GB2006003650 | Int. publication no. | WO2007036745 | Related patent (certificate) | CA 2021 00043 | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|